The novel treatment of tirzepatide peptide represents a exciting development in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets multiple pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment